Bactiguard Holding AB (publ)
Bactiguard Holding AB (publ) (0QV2.L) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Bactiguard Holding AB (publ) (0QV2.L), covering cash flow, earnings, and balance sheets.
Bactiguard Holding AB (publ) (0QV2.L) Income Statement & Financial Overview
Explore comprehensive income reports for Bactiguard Holding AB (publ) 0QV2.L, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $59.05M | $68.26M | $73.94M | $57.35M |
Cost of Revenue | $10.97M | $5.46M | $7.20M | $70.40M |
Gross Profit | $48.08M | $62.80M | $66.74M | -$13.05M |
Gross Profit Ratio | $0.81 | $0.92 | $0.90 | -$0.23 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $6.30M |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $46.48M |
Operating Expenses | $50.70M | $66.001M | $68.68M | $59.88M |
Total Costs & Expenses | $61.66M | $71.46M | $75.88M | $70.40M |
Interest Income | $16000.00 | $4.11M | $0.00 | $0.00 |
Interest Expense | $4.88M | $3.26M | $4.19M | $5.04M |
Depreciation & Amortization | $12.02M | $8.10M | $19.03M | $12.06M |
EBITDA | $9.43M | $12.54M | $17.09M | -$989000.00 |
EBITDA Ratio | $0.16 | $0.18 | $0.23 | -$0.02 |
Operating Income | -$2.61M | -$3.20M | -$1.94M | -$13.05M |
Operating Income Ratio | -$0.04 | -$0.05 | -$0.03 | -$0.23 |
Other Income/Expenses (Net) | -$4.87M | $844000.00 | -$4.19M | -$5.04M |
Income Before Tax | -$7.48M | -$2.36M | -$6.13M | -$15.89M |
Income Before Tax Ratio | -$0.13 | -$0.03 | -$0.08 | -$0.28 |
Income Tax Expense | -$2.75M | -$1.44M | -$1.46M | -$1.57M |
Net Income | -$4.73M | -$920000.00 | -$4.67M | -$14.32M |
Net Income Ratio | -$0.08 | -$0.01 | -$0.06 | -$0.25 |
EPS | -$0.13 | -$0.03 | -$0.13 | -$0.41 |
Diluted EPS | -$0.13 | -$0.03 | -$0.13 | -$0.41 |
Weighted Avg Shares Outstanding | $35.04M | $35.04M | $35.04M | $35.04M |
Weighted Avg Shares Outstanding (Diluted) | $35.04M | $35.04M | $35.04M | $35.04M |
Over the last four quarters, Bactiguard Holding AB (publ)'s revenue moved from $57.35M in Q2 2024 to $59.05M in Q1 2025. Operating income in Q1 2025 was -$2.61M, with a strong operating margin of -4%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Bactiguard Holding AB (publ) remained robust at $9.43M, reflecting operational efficiency. Net income dropped to -$4.73M, with an EPS of -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan